Original Article The safety of first and subsequent lines of PD-1/PD-L1 inhibitors monotherapy in non-small cell lung cancer patients: a meta-analysis Yilin Yang, Peilin Pang, Zihong Xie, Nian Wang, Hengrui Liang, Lei Zhao
